reference/8066118

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8066118

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	e1593
issn	2041-4889
issueIdentifier	1
pageRange	e1593-e1593
publicationName	Cell Death & Disease
startingPage	e1593
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ba1a5c3a9c1aaeaab49f830de313aba8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_def93fe74dde260538bc6ad18a0e8396 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7e3590236023723ad4a6dd922414ab74
bibliographicCitation	Choudhary GS, Al-harbi S, Mazumder S, Hill BT, Smith MR, Bodo J, Hsi ED, Almasan A. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies. Cell Death & Disease. 2015 Jan 15;6(1):e1593. doi: 10.1038/cddis.2014.525.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3ee57d0f13e4f9cde84373d68d5bbca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41b57b31d348eabbe81bb034c6159a90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_166ee5174ece0b14af235d6176a44b7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ee9de1a3c9c60e63bf65aa1eeecc0d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8916-6650 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6deb46a34c622cb843f16f993aaaaf4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7d7f5fead5bd93413d8285dd222ce9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5830ec1d22cdf5561aabce7729404a5a
date	2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/cddis.2014.525 https://pubmed.ncbi.nlm.nih.gov/PMC4669737 https://pubmed.ncbi.nlm.nih.gov/25590803
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37956 https://portal.issn.org/resource/ISSN/2041-4889
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
discusses	http://id.nlm.nih.gov/mesh/M0592589 http://id.nlm.nih.gov/mesh/M0478975 http://id.nlm.nih.gov/mesh/M0578123 http://id.nlm.nih.gov/mesh/M0220648 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0028488 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0474909 http://id.nlm.nih.gov/mesh/M0150739 http://id.nlm.nih.gov/mesh/M0286286 http://id.nlm.nih.gov/mesh/M0018350 http://id.nlm.nih.gov/mesh/M000614617 http://id.nlm.nih.gov/mesh/M0490629 http://id.nlm.nih.gov/mesh/M0013341 http://id.nlm.nih.gov/mesh/M0430377 http://id.nlm.nih.gov/mesh/M0017909 http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0215606 http://id.nlm.nih.gov/mesh/M0018169
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/06 http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11625818 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0c1bbc5947dc7d50c3960aba9470b9d4 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11977753 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e75b04b99ad7f9547bbdf30bf933fe9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9720 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24978538 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0f74772abfdf1a85101c7bea3e0480ac http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4170 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID598

Total number of triples: 73.